Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)

Details

Request a copyRequest a copy
Serval ID
serval:BIB_5B937E4FA559
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Production externe
Title
Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)
Title of the conference
Blood
Author(s)
Bahlis Nizar J., Richard Shambavi, White Darrell J., Grosicki Sebastian, Chen Christine, Delimpasi Sosana, Sutherland Heather J., Maslyak Zvenyslava, Sebag Michael, Gavriatopoulou Maria, Lentzsch Suzanne, Chari Ajai, Simonova Maryana, Spicka Ivan, Kriachok Iryna, Dimopoulos Meletios A., Pylypenko Halyna, Auner Holger W, Leleu Xavier, Usenko Ganna, Hajek Roman, Benjamin Reuben, Dolai Tuphan Kanti, Sinha Dinesh Kumar, Venner Christopher P., Garg Mamta, Stevens Don, Quach Hang, Jagannath Sundar, Moreau Philippe, Levy Moshe, Badros Ashraf Z., Anderson Larry D., Facon Thierry, Mateos Maria-Victoria, Cavo Michele, DeCastro Andrew, Chai Yi, Van Domelen Dane R., Mishal Moran, Bentur Ohad S., Shah Jatin, Shacham Sharon, Kauffman Michael G., Richardson Paul G.
Publisher
American Society of Hematology
Organization
63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Address
Atlanta, GA
ISSN
0006-4971
1528-0020
Publication state
Published
Issued date
05/11/2021
Volume
138
Number
Supplement 1
Pages
1634-1634
Language
english
DOI
10.1182/blood-2021-146324
Web of science
000736398806103
Open Access
Yes
Create date
02/12/2024 16:49
Last modification date
04/12/2024 7:07
Usage data